by Clinical Neuropsychologist | Tuesday, November 12, 2024 | Dementia
Abstract INTRODUCTION We investigate sex-specific topological structures associated with typical Alzheimer’s disease (AD) dementia using a novel state-of-the-art latent space estimation technique. METHODS This study applies a probabilistic approach for latent...
by Clinical Neuropsychologist | Friday, November 8, 2024 | Dementia
Abstract INTRODUCTION Despite the recognized importance of including ethnic diversity in Alzheimer’s disease (AD) research, substantial knowledge gaps remain, particularly in Asian populations. METHODS RNA sequencing was performed on blood samples from the...
by Clinical Neuropsychologist | Friday, November 8, 2024 | Dementia
Abstract INTRODUCTION Semorinemab, an anti-tau monoclonal antibody, was assessed in two Phase II trials for Alzheimer’s disease (AD). Plasma and cerebrospinal fluid (CSF) biomarkers provided insights into the drug’s potential mechanism of action. METHODS...
by Clinical Neuropsychologist | Friday, November 8, 2024 | Dementia
Abstract Dementia prevention in Africa is critically underexplored, despite the continent’s high prevalence of modifiable risk factors. With a predominantly young and middle-aged population, Africa presents a prime opportunity to implement evidence-based...
by Clinical Neuropsychologist | Friday, November 8, 2024 | Dementia
Abstract INTRODUCTION The Health Equity Scholars Program (HESP) addresses the critical need for a diverse, culturally competent workforce to study and treat older adults from underrepresented populations (URPs) with Alzheimer’s disease and related dementias...
